We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (20 December 2024) granted a conditional marketing authorisation for the medicine givinostat (Duvyzat) to treat Duchenne muscular dystrophy (DMD).
You must tell DVLA if you have muscular dystrophy - download the correct form to let them know.
Advice for medical professionals to follow when assessing drivers with neurological disorders.
National data on the prevalence of spinal muscular atrophy type 1 (SMA1) from the National Congenital Anomaly and Rare Disease Registration Service.
Projects granted during 2015 that have a primary purpose of basic research: musculoskeletal system.
Find out what information you need to show on products made of or containing meat that you sell to the public.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).